Global Prostate-Specific Antigen (PSA) Test Market Insights and Forecast to 2028

Report ID: 1750156 | Published Date: Jan 2025 | No. of Page: 109 | Base Year: 2024 | Rating: 3.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Prostate-Specific Antigen (PSA) Test Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 CLIA
        1.2.3 ELISA
        1.2.4 Other
    1.3 Market by Application
        1.3.1 Global Prostate-Specific Antigen (PSA) Test Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Screening
        1.3.3 Post-treatment Monitoring
        1.3.4 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Prostate-Specific Antigen (PSA) Test Market Perspective (2017-2028)
    2.2 Prostate-Specific Antigen (PSA) Test Growth Trends by Region
        2.2.1 Prostate-Specific Antigen (PSA) Test Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Prostate-Specific Antigen (PSA) Test Historic Market Size by Region (2017-2022)
        2.2.3 Prostate-Specific Antigen (PSA) Test Forecasted Market Size by Region (2023-2028)
    2.3 Prostate-Specific Antigen (PSA) Test Market Dynamics
        2.3.1 Prostate-Specific Antigen (PSA) Test Industry Trends
        2.3.2 Prostate-Specific Antigen (PSA) Test Market Drivers
        2.3.3 Prostate-Specific Antigen (PSA) Test Market Challenges
        2.3.4 Prostate-Specific Antigen (PSA) Test Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Prostate-Specific Antigen (PSA) Test Players by Revenue
        3.1.1 Global Top Prostate-Specific Antigen (PSA) Test Players by Revenue (2017-2022)
        3.1.2 Global Prostate-Specific Antigen (PSA) Test Revenue Market Share by Players (2017-2022)
    3.2 Global Prostate-Specific Antigen (PSA) Test Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Prostate-Specific Antigen (PSA) Test Revenue
    3.4 Global Prostate-Specific Antigen (PSA) Test Market Concentration Ratio
        3.4.1 Global Prostate-Specific Antigen (PSA) Test Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Prostate-Specific Antigen (PSA) Test Revenue in 2021
    3.5 Prostate-Specific Antigen (PSA) Test Key Players Head office and Area Served
    3.6 Key Players Prostate-Specific Antigen (PSA) Test Product Solution and Service
    3.7 Date of Enter into Prostate-Specific Antigen (PSA) Test Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Prostate-Specific Antigen (PSA) Test Breakdown Data by Type
    4.1 Global Prostate-Specific Antigen (PSA) Test Historic Market Size by Type (2017-2022)
    4.2 Global Prostate-Specific Antigen (PSA) Test Forecasted Market Size by Type (2023-2028)
5 Prostate-Specific Antigen (PSA) Test Breakdown Data by Application
    5.1 Global Prostate-Specific Antigen (PSA) Test Historic Market Size by Application (2017-2022)
    5.2 Global Prostate-Specific Antigen (PSA) Test Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Prostate-Specific Antigen (PSA) Test Market Size (2017-2028)
    6.2 North America Prostate-Specific Antigen (PSA) Test Market Size by Type
        6.2.1 North America Prostate-Specific Antigen (PSA) Test Market Size by Type (2017-2022)
        6.2.2 North America Prostate-Specific Antigen (PSA) Test Market Size by Type (2023-2028)
        6.2.3 North America Prostate-Specific Antigen (PSA) Test Market Share by Type (2017-2028)
    6.3 North America Prostate-Specific Antigen (PSA) Test Market Size by Application
        6.3.1 North America Prostate-Specific Antigen (PSA) Test Market Size by Application (2017-2022)
        6.3.2 North America Prostate-Specific Antigen (PSA) Test Market Size by Application (2023-2028)
        6.3.3 North America Prostate-Specific Antigen (PSA) Test Market Share by Application (2017-2028)
    6.4 North America Prostate-Specific Antigen (PSA) Test Market Size by Country
        6.4.1 North America Prostate-Specific Antigen (PSA) Test Market Size by Country (2017-2022)
        6.4.2 North America Prostate-Specific Antigen (PSA) Test Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Prostate-Specific Antigen (PSA) Test Market Size (2017-2028)
    7.2 Europe Prostate-Specific Antigen (PSA) Test Market Size by Type
        7.2.1 Europe Prostate-Specific Antigen (PSA) Test Market Size by Type (2017-2022)
        7.2.2 Europe Prostate-Specific Antigen (PSA) Test Market Size by Type (2023-2028)
        7.2.3 Europe Prostate-Specific Antigen (PSA) Test Market Share by Type (2017-2028)
    7.3 Europe Prostate-Specific Antigen (PSA) Test Market Size by Application
        7.3.1 Europe Prostate-Specific Antigen (PSA) Test Market Size by Application (2017-2022)
        7.3.2 Europe Prostate-Specific Antigen (PSA) Test Market Size by Application (2023-2028)
        7.3.3 Europe Prostate-Specific Antigen (PSA) Test Market Share by Application (2017-2028)
    7.4 Europe Prostate-Specific Antigen (PSA) Test Market Size by Country
        7.4.1 Europe Prostate-Specific Antigen (PSA) Test Market Size by Country (2017-2022)
        7.4.2 Europe Prostate-Specific Antigen (PSA) Test Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Prostate-Specific Antigen (PSA) Test Market Size (2017-2028)
    8.2 Asia-Pacific Prostate-Specific Antigen (PSA) Test Market Size by Type
        8.2.1 Asia-Pacific Prostate-Specific Antigen (PSA) Test Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Prostate-Specific Antigen (PSA) Test Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Prostate-Specific Antigen (PSA) Test Market Share by Type (2017-2028)
    8.3 Asia-Pacific Prostate-Specific Antigen (PSA) Test Market Size by Application
        8.3.1 Asia-Pacific Prostate-Specific Antigen (PSA) Test Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Prostate-Specific Antigen (PSA) Test Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Prostate-Specific Antigen (PSA) Test Market Share by Application (2017-2028)
    8.4 Asia-Pacific Prostate-Specific Antigen (PSA) Test Market Size by Region
        8.4.1 Asia-Pacific Prostate-Specific Antigen (PSA) Test Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Prostate-Specific Antigen (PSA) Test Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Prostate-Specific Antigen (PSA) Test Market Size (2017-2028)
    9.2 Latin America Prostate-Specific Antigen (PSA) Test Market Size by Type
        9.2.1 Latin America Prostate-Specific Antigen (PSA) Test Market Size by Type (2017-2022)
        9.2.2 Latin America Prostate-Specific Antigen (PSA) Test Market Size by Type (2023-2028)
        9.2.3 Latin America Prostate-Specific Antigen (PSA) Test Market Share by Type (2017-2028)
    9.3 Latin America Prostate-Specific Antigen (PSA) Test Market Size by Application
        9.3.1 Latin America Prostate-Specific Antigen (PSA) Test Market Size by Application (2017-2022)
        9.3.2 Latin America Prostate-Specific Antigen (PSA) Test Market Size by Application (2023-2028)
        9.3.3 Latin America Prostate-Specific Antigen (PSA) Test Market Share by Application (2017-2028)
    9.4 Latin America Prostate-Specific Antigen (PSA) Test Market Size by Country
        9.4.1 Latin America Prostate-Specific Antigen (PSA) Test Market Size by Country (2017-2022)
        9.4.2 Latin America Prostate-Specific Antigen (PSA) Test Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Prostate-Specific Antigen (PSA) Test Market Size (2017-2028)
    10.2 Middle East & Africa Prostate-Specific Antigen (PSA) Test Market Size by Type
        10.2.1 Middle East & Africa Prostate-Specific Antigen (PSA) Test Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Prostate-Specific Antigen (PSA) Test Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Prostate-Specific Antigen (PSA) Test Market Share by Type (2017-2028)
    10.3 Middle East & Africa Prostate-Specific Antigen (PSA) Test Market Size by Application
        10.3.1 Middle East & Africa Prostate-Specific Antigen (PSA) Test Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Prostate-Specific Antigen (PSA) Test Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Prostate-Specific Antigen (PSA) Test Market Share by Application (2017-2028)
    10.4 Middle East & Africa Prostate-Specific Antigen (PSA) Test Market Size by Country
        10.4.1 Middle East & Africa Prostate-Specific Antigen (PSA) Test Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Prostate-Specific Antigen (PSA) Test Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Abbott
        11.1.1 Abbott Company Details
        11.1.2 Abbott Business Overview
        11.1.3 Abbott Prostate-Specific Antigen (PSA) Test Introduction
        11.1.4 Abbott Revenue in Prostate-Specific Antigen (PSA) Test Business (2017-2022)
        11.1.5 Abbott Recent Developments
    11.2 Siemens Healthcare
        11.2.1 Siemens Healthcare Company Details
        11.2.2 Siemens Healthcare Business Overview
        11.2.3 Siemens Healthcare Prostate-Specific Antigen (PSA) Test Introduction
        11.2.4 Siemens Healthcare Revenue in Prostate-Specific Antigen (PSA) Test Business (2017-2022)
        11.2.5 Siemens Healthcare Recent Developments
    11.3 DiaSorin
        11.3.1 DiaSorin Company Details
        11.3.2 DiaSorin Business Overview
        11.3.3 DiaSorin Prostate-Specific Antigen (PSA) Test Introduction
        11.3.4 DiaSorin Revenue in Prostate-Specific Antigen (PSA) Test Business (2017-2022)
        11.3.5 DiaSorin Recent Developments
    11.4 Roche
        11.4.1 Roche Company Details
        11.4.2 Roche Business Overview
        11.4.3 Roche Prostate-Specific Antigen (PSA) Test Introduction
        11.4.4 Roche Revenue in Prostate-Specific Antigen (PSA) Test Business (2017-2022)
        11.4.5 Roche Recent Developments
    11.5 Beckman Coulter
        11.5.1 Beckman Coulter Company Details
        11.5.2 Beckman Coulter Business Overview
        11.5.3 Beckman Coulter Prostate-Specific Antigen (PSA) Test Introduction
        11.5.4 Beckman Coulter Revenue in Prostate-Specific Antigen (PSA) Test Business (2017-2022)
        11.5.5 Beckman Coulter Recent Developments
    11.6 PerkinElmer
        11.6.1 PerkinElmer Company Details
        11.6.2 PerkinElmer Business Overview
        11.6.3 PerkinElmer Prostate-Specific Antigen (PSA) Test Introduction
        11.6.4 PerkinElmer Revenue in Prostate-Specific Antigen (PSA) Test Business (2017-2022)
        11.6.5 PerkinElmer Recent Developments
    11.7 Tosoh
        11.7.1 Tosoh Company Details
        11.7.2 Tosoh Business Overview
        11.7.3 Tosoh Prostate-Specific Antigen (PSA) Test Introduction
        11.7.4 Tosoh Revenue in Prostate-Specific Antigen (PSA) Test Business (2017-2022)
        11.7.5 Tosoh Recent Developments
    11.8 Ortho Clinical
        11.8.1 Ortho Clinical Company Details
        11.8.2 Ortho Clinical Business Overview
        11.8.3 Ortho Clinical Prostate-Specific Antigen (PSA) Test Introduction
        11.8.4 Ortho Clinical Revenue in Prostate-Specific Antigen (PSA) Test Business (2017-2022)
        11.8.5 Ortho Clinical Recent Developments
    11.9 Fujirebio
        11.9.1 Fujirebio Company Details
        11.9.2 Fujirebio Business Overview
        11.9.3 Fujirebio Prostate-Specific Antigen (PSA) Test Introduction
        11.9.4 Fujirebio Revenue in Prostate-Specific Antigen (PSA) Test Business (2017-2022)
        11.9.5 Fujirebio Recent Developments
    11.10 Mediwatch (LABORIE)
        11.10.1 Mediwatch (LABORIE) Company Details
        11.10.2 Mediwatch (LABORIE) Business Overview
        11.10.3 Mediwatch (LABORIE) Prostate-Specific Antigen (PSA) Test Introduction
        11.10.4 Mediwatch (LABORIE) Revenue in Prostate-Specific Antigen (PSA) Test Business (2017-2022)
        11.10.5 Mediwatch (LABORIE) Recent Developments
    11.11 BodiTech
        11.11.1 BodiTech Company Details
        11.11.2 BodiTech Business Overview
        11.11.3 BodiTech Prostate-Specific Antigen (PSA) Test Introduction
        11.11.4 BodiTech Revenue in Prostate-Specific Antigen (PSA) Test Business (2017-2022)
        11.11.5 BodiTech Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer

List of Tables
    Table 1. Global Prostate-Specific Antigen (PSA) Test Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of CLIA
    Table 3. Key Players of ELISA
    Table 4. Key Players of Other
    Table 5. Global Prostate-Specific Antigen (PSA) Test Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 6. Global Prostate-Specific Antigen (PSA) Test Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Prostate-Specific Antigen (PSA) Test Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global Prostate-Specific Antigen (PSA) Test Market Share by Region (2017-2022)
    Table 9. Global Prostate-Specific Antigen (PSA) Test Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global Prostate-Specific Antigen (PSA) Test Market Share by Region (2023-2028)
    Table 11. Prostate-Specific Antigen (PSA) Test Market Trends
    Table 12. Prostate-Specific Antigen (PSA) Test Market Drivers
    Table 13. Prostate-Specific Antigen (PSA) Test Market Challenges
    Table 14. Prostate-Specific Antigen (PSA) Test Market Restraints
    Table 15. Global Prostate-Specific Antigen (PSA) Test Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global Prostate-Specific Antigen (PSA) Test Revenue Share by Players (2017-2022)
    Table 17. Global Top Prostate-Specific Antigen (PSA) Test by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate-Specific Antigen (PSA) Test as of 2021)
    Table 18. Ranking of Global Top Prostate-Specific Antigen (PSA) Test Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by Prostate-Specific Antigen (PSA) Test Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Prostate-Specific Antigen (PSA) Test Product Solution and Service
    Table 22. Date of Enter into Prostate-Specific Antigen (PSA) Test Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Prostate-Specific Antigen (PSA) Test Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global Prostate-Specific Antigen (PSA) Test Revenue Market Share by Type (2017-2022)
    Table 26. Global Prostate-Specific Antigen (PSA) Test Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global Prostate-Specific Antigen (PSA) Test Revenue Market Share by Type (2023-2028)
    Table 28. Global Prostate-Specific Antigen (PSA) Test Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global Prostate-Specific Antigen (PSA) Test Revenue Share by Application (2017-2022)
    Table 30. Global Prostate-Specific Antigen (PSA) Test Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global Prostate-Specific Antigen (PSA) Test Revenue Share by Application (2023-2028)
    Table 32. North America Prostate-Specific Antigen (PSA) Test Market Size by Type (2017-2022) & (US$ Million)
    Table 33. North America Prostate-Specific Antigen (PSA) Test Market Size by Type (2023-2028) & (US$ Million)
    Table 34. North America Prostate-Specific Antigen (PSA) Test Market Size by Application (2017-2022) & (US$ Million)
    Table 35. North America Prostate-Specific Antigen (PSA) Test Market Size by Application (2023-2028) & (US$ Million)
    Table 36. North America Prostate-Specific Antigen (PSA) Test Market Size by Country (2017-2022) & (US$ Million)
    Table 37. North America Prostate-Specific Antigen (PSA) Test Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Europe Prostate-Specific Antigen (PSA) Test Market Size by Type (2017-2022) & (US$ Million)
    Table 39. Europe Prostate-Specific Antigen (PSA) Test Market Size by Type (2023-2028) & (US$ Million)
    Table 40. Europe Prostate-Specific Antigen (PSA) Test Market Size by Application (2017-2022) & (US$ Million)
    Table 41. Europe Prostate-Specific Antigen (PSA) Test Market Size by Application (2023-2028) & (US$ Million)
    Table 42. Europe Prostate-Specific Antigen (PSA) Test Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Europe Prostate-Specific Antigen (PSA) Test Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Asia Pacific Prostate-Specific Antigen (PSA) Test Market Size by Type (2017-2022) & (US$ Million)
    Table 45. Asia Pacific Prostate-Specific Antigen (PSA) Test Market Size by Type (2023-2028) & (US$ Million)
    Table 46. Asia Pacific Prostate-Specific Antigen (PSA) Test Market Size by Application (2017-2022) & (US$ Million)
    Table 47. Asia Pacific Prostate-Specific Antigen (PSA) Test Market Size by Application (2023-2028) & (US$ Million)
    Table 48. Asia Pacific Prostate-Specific Antigen (PSA) Test Market Size by Region (2017-2022) & (US$ Million)
    Table 49. Asia Pacific Prostate-Specific Antigen (PSA) Test Market Size by Region (2023-2028) & (US$ Million)
    Table 50. Latin America Prostate-Specific Antigen (PSA) Test Market Size by Type (2017-2022) & (US$ Million)
    Table 51. Latin America Prostate-Specific Antigen (PSA) Test Market Size by Type (2023-2028) & (US$ Million)
    Table 52. Latin America Prostate-Specific Antigen (PSA) Test Market Size by Application (2017-2022) & (US$ Million)
    Table 53. Latin America Prostate-Specific Antigen (PSA) Test Market Size by Application (2023-2028) & (US$ Million)
    Table 54. Latin America Prostate-Specific Antigen (PSA) Test Market Size by Country (2017-2022) & (US$ Million)
    Table 55. Latin America Prostate-Specific Antigen (PSA) Test Market Size by Country (2023-2028) & (US$ Million)
    Table 56. Middle East and Africa Prostate-Specific Antigen (PSA) Test Market Size by Type (2017-2022) & (US$ Million)
    Table 57. Middle East and Africa Prostate-Specific Antigen (PSA) Test Market Size by Type (2023-2028) & (US$ Million)
    Table 58. Middle East and Africa Prostate-Specific Antigen (PSA) Test Market Size by Application (2017-2022) & (US$ Million)
    Table 59. Middle East and Africa Prostate-Specific Antigen (PSA) Test Market Size by Application (2023-2028) & (US$ Million)
    Table 60. Middle East and Africa Prostate-Specific Antigen (PSA) Test Market Size by Country (2017-2022) & (US$ Million)
    Table 61. Middle East and Africa Prostate-Specific Antigen (PSA) Test Market Size by Country (2023-2028) & (US$ Million)
    Table 62. Abbott Company Details
    Table 63. Abbott Business Overview
    Table 64. Abbott Prostate-Specific Antigen (PSA) Test Product
    Table 65. Abbott Revenue in Prostate-Specific Antigen (PSA) Test Business (2017-2022) & (US$ Million)
    Table 66. Abbott Recent Developments
    Table 67. Siemens Healthcare Company Details
    Table 68. Siemens Healthcare Business Overview
    Table 69. Siemens Healthcare Prostate-Specific Antigen (PSA) Test Product
    Table 70. Siemens Healthcare Revenue in Prostate-Specific Antigen (PSA) Test Business (2017-2022) & (US$ Million)
    Table 71. Siemens Healthcare Recent Developments
    Table 72. DiaSorin Company Details
    Table 73. DiaSorin Business Overview
    Table 74. DiaSorin Prostate-Specific Antigen (PSA) Test Product
    Table 75. DiaSorin Revenue in Prostate-Specific Antigen (PSA) Test Business (2017-2022) & (US$ Million)
    Table 76. DiaSorin Recent Developments
    Table 77. Roche Company Details
    Table 78. Roche Business Overview
    Table 79. Roche Prostate-Specific Antigen (PSA) Test Product
    Table 80. Roche Revenue in Prostate-Specific Antigen (PSA) Test Business (2017-2022) & (US$ Million)
    Table 81. Roche Recent Developments
    Table 82. Beckman Coulter Company Details
    Table 83. Beckman Coulter Business Overview
    Table 84. Beckman Coulter Prostate-Specific Antigen (PSA) Test Product
    Table 85. Beckman Coulter Revenue in Prostate-Specific Antigen (PSA) Test Business (2017-2022) & (US$ Million)
    Table 86. Beckman Coulter Recent Developments
    Table 87. PerkinElmer Company Details
    Table 88. PerkinElmer Business Overview
    Table 89. PerkinElmer Prostate-Specific Antigen (PSA) Test Product
    Table 90. PerkinElmer Revenue in Prostate-Specific Antigen (PSA) Test Business (2017-2022) & (US$ Million)
    Table 91. PerkinElmer Recent Developments
    Table 92. Tosoh Company Details
    Table 93. Tosoh Business Overview
    Table 94. Tosoh Prostate-Specific Antigen (PSA) Test Product
    Table 95. Tosoh Revenue in Prostate-Specific Antigen (PSA) Test Business (2017-2022) & (US$ Million)
    Table 96. Tosoh Recent Developments
    Table 97. Ortho Clinical Company Details
    Table 98. Ortho Clinical Business Overview
    Table 99. Ortho Clinical Prostate-Specific Antigen (PSA) Test Product
    Table 100. Ortho Clinical Revenue in Prostate-Specific Antigen (PSA) Test Business (2017-2022) & (US$ Million)
    Table 101. Ortho Clinical Recent Developments
    Table 102. Fujirebio Company Details
    Table 103. Fujirebio Business Overview
    Table 104. Fujirebio Prostate-Specific Antigen (PSA) Test Product
    Table 105. Fujirebio Revenue in Prostate-Specific Antigen (PSA) Test Business (2017-2022) & (US$ Million)
    Table 106. Fujirebio Recent Developments
    Table 107. Mediwatch (LABORIE) Company Details
    Table 108. Mediwatch (LABORIE) Business Overview
    Table 109. Mediwatch (LABORIE) Prostate-Specific Antigen (PSA) Test Product
    Table 110. Mediwatch (LABORIE) Revenue in Prostate-Specific Antigen (PSA) Test Business (2017-2022) & (US$ Million)
    Table 111. Mediwatch (LABORIE) Recent Developments
    Table 112. BodiTech Company Details
    Table 113. BodiTech Business Overview
    Table 114. BodiTech Prostate-Specific Antigen (PSA) Test Product
    Table 115. BodiTech Revenue in Prostate-Specific Antigen (PSA) Test Business (2017-2022) & (US$ Million)
    Table 116. BodiTech Recent Developments
    Table 117. Research Programs/Design for This Report
    Table 118. Key Data Information from Secondary Sources
    Table 119. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Prostate-Specific Antigen (PSA) Test Market Share by Type: 2021 VS 2028
    Figure 2. CLIA Features
    Figure 3. ELISA Features
    Figure 4. Other Features
    Figure 5. Global Prostate-Specific Antigen (PSA) Test Market Share by Application: 2021 VS 2028
    Figure 6. Screening Case Studies
    Figure 7. Post-treatment Monitoring Case Studies
    Figure 8. Other Case Studies
    Figure 9. Prostate-Specific Antigen (PSA) Test Report Years Considered
    Figure 10. Global Prostate-Specific Antigen (PSA) Test Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 11. Global Prostate-Specific Antigen (PSA) Test Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Prostate-Specific Antigen (PSA) Test Market Share by Region: 2021 VS 2028
    Figure 13. Global Prostate-Specific Antigen (PSA) Test Market Share by Players in 2021
    Figure 14. Global Top Prostate-Specific Antigen (PSA) Test Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate-Specific Antigen (PSA) Test as of 2021)
    Figure 15. The Top 10 and 5 Players Market Share by Prostate-Specific Antigen (PSA) Test Revenue in 2021
    Figure 16. North America Prostate-Specific Antigen (PSA) Test Market Size YoY (2017-2028) & (US$ Million)
    Figure 17. North America Prostate-Specific Antigen (PSA) Test Market Size Market Share by Type (2017-2028)
    Figure 18. North America Prostate-Specific Antigen (PSA) Test Market Size Market Share by Application (2017-2028)
    Figure 19. North America Prostate-Specific Antigen (PSA) Test Market Size Share by Country (2017-2028)
    Figure 20. United States Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Canada Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Prostate-Specific Antigen (PSA) Test Market Size YoY (2017-2028) & (US$ Million)
    Figure 23. Europe Prostate-Specific Antigen (PSA) Test Market Size Market Share by Type (2017-2028)
    Figure 24. Europe Prostate-Specific Antigen (PSA) Test Market Size Market Share by Application (2017-2028)
    Figure 25. Europe Prostate-Specific Antigen (PSA) Test Market Size Share by Country (2017-2028)
    Figure 26. Germany Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. France Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. U.K. Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Italy Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Russia Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Nordic Countries Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Asia-Pacific Prostate-Specific Antigen (PSA) Test Market Size YoY (2017-2028) & (US$ Million)
    Figure 33. Asia Pacific Prostate-Specific Antigen (PSA) Test Market Size Market Share by Type (2017-2028)
    Figure 34. Asia Pacific Prostate-Specific Antigen (PSA) Test Market Size Market Share by Application (2017-2028)
    Figure 35. Asia Pacific Prostate-Specific Antigen (PSA) Test Market Size Share by Region (2017-2028)
    Figure 36. China Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Japan Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. South Korea Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Southeast Asia Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. India Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Australia Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 42. Latin America Prostate-Specific Antigen (PSA) Test Market Size YoY (2017-2028) & (US$ Million)
    Figure 43. Latin America Prostate-Specific Antigen (PSA) Test Market Size Market Share by Type (2017-2028)
    Figure 44. Latin America Prostate-Specific Antigen (PSA) Test Market Size Market Share by Application (2017-2028)
    Figure 45. Latin America Prostate-Specific Antigen (PSA) Test Market Size Share by Country (2017-2028)
    Figure 46. Mexico Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Brazil Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Middle East & Africa Prostate-Specific Antigen (PSA) Test Market Size YoY (2017-2028) & (US$ Million)
    Figure 49. Middle East and Africa Prostate-Specific Antigen (PSA) Test Market Size Market Share by Type (2017-2028)
    Figure 50. Middle East and Africa Prostate-Specific Antigen (PSA) Test Market Size Market Share by Application (2017-2028)
    Figure 51. Middle East and Africa Prostate-Specific Antigen (PSA) Test Market Size Share by Country (2017-2028)
    Figure 52. Turkey Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. Saudi Arabia Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. UAE Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. Abbott Revenue Growth Rate in Prostate-Specific Antigen (PSA) Test Business (2017-2022)
    Figure 56. Siemens Healthcare Revenue Growth Rate in Prostate-Specific Antigen (PSA) Test Business (2017-2022)
    Figure 57. DiaSorin Revenue Growth Rate in Prostate-Specific Antigen (PSA) Test Business (2017-2022)
    Figure 58. Roche Revenue Growth Rate in Prostate-Specific Antigen (PSA) Test Business (2017-2022)
    Figure 59. Beckman Coulter Revenue Growth Rate in Prostate-Specific Antigen (PSA) Test Business (2017-2022)
    Figure 60. PerkinElmer Revenue Growth Rate in Prostate-Specific Antigen (PSA) Test Business (2017-2022)
    Figure 61. Tosoh Revenue Growth Rate in Prostate-Specific Antigen (PSA) Test Business (2017-2022)
    Figure 62. Ortho Clinical Revenue Growth Rate in Prostate-Specific Antigen (PSA) Test Business (2017-2022)
    Figure 63. Fujirebio Revenue Growth Rate in Prostate-Specific Antigen (PSA) Test Business (2017-2022)
    Figure 64. Mediwatch (LABORIE) Revenue Growth Rate in Prostate-Specific Antigen (PSA) Test Business (2017-2022)
    Figure 65. BodiTech Revenue Growth Rate in Prostate-Specific Antigen (PSA) Test Business (2017-2022)
    Figure 66. Bottom-up and Top-down Approaches for This Report
    Figure 67. Data Triangulation
    Figure 68. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Abbott
Siemens Healthcare
DiaSorin
Roche
Beckman Coulter
PerkinElmer
Tosoh
Ortho Clinical
Fujirebio
Mediwatch (LABORIE)
BodiTech
Frequently Asked Questions
Prostate-Specific Antigen (PSA) Test report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Prostate-Specific Antigen (PSA) Test report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Prostate-Specific Antigen (PSA) Test report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Plate Reader

Plate Reader market is segmented by Type and by Application. Players, stakeholders, and other par ... Read More

Backup Camera

Backup Camera market is segmented by Type and by Application. Players, stakeholders, and other pa ... Read More